Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...
Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a ...